Literature DB >> 11751951

NK cell activation by dendritic cells is dependent on LFA-1-mediated induction of calcium-calmodulin kinase II: inhibition by HIV-1 Tat C-terminal domain.

Alessandro Poggi1, Roberta Carosio, Grazia Maria Spaggiari, Claudio Fortis, Giuseppe Tambussi, Giacomo Dell'Antonio, Elena Dal Cin, Anna Rubartelli, M Raffaella Zocchi.   

Abstract

In this study, we show that binding to autologous dendritic cells (DC) induces a calcium influx in NK cells, followed by activation of the calcium-calmodulin kinase II (CAMKII), release of perforin and granzymes, and IFN-gamma secretion. CAMKII is induced via LFA-1: indeed, oligomerization of LFA-1 leads to CAMKII induction in NK cells. Moreover, release of lytic enzymes and cytotoxic activity is strongly reduced by masking LFA-1 or by adding CAMKII inhibitors such as KN62 and KN93, at variance with the inactive compound KN92. NK cell-mediated lysis of DC and IFN-gamma release by NK cells upon NK/DC contact are inhibited by exogenous HIV-1 Tat: the protein blocks calcium influx and impairs CAMKII activation elicited via LFA-1 in NK cells, eventually inhibiting degranulation. Experiments performed with synthetic, overlapping Tat-derived peptides showed that the C-terminal domain of the protein is responsible for inhibition. Finally, both KN62 and Tat reduced the extension of NK/DC contacts, possibly affecting NK cell granule polarization toward the target. These data provide evidence that exogenous Tat inhibits NK cell activation occurring upon contact with DC: this mechanism might contribute to the impairment of natural immunity in HIV-1 infection.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11751951     DOI: 10.4049/jimmunol.168.1.95

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  17 in total

1.  Why does GM1 induce a potent beneficial response to experimental Chagas disease?

Authors:  S Cossy Isasi; C A Condat; G J Sibona
Journal:  HFSP J       Date:  2009-01-21

Review 2.  DCs and NK cells: critical effectors in the immune response to HIV-1.

Authors:  Marcus Altfeld; Lena Fadda; Davor Frleta; Nina Bhardwaj
Journal:  Nat Rev Immunol       Date:  2011-03       Impact factor: 53.106

Review 3.  Natural killer cell activation by dendritic cells: balancing inhibitory and activating signals.

Authors:  Rosa Barreira da Silva; Christian Münz
Journal:  Cell Mol Life Sci       Date:  2011-08-23       Impact factor: 9.261

Review 4.  Role of TNF superfamily ligands in innate immunity.

Authors:  Nikola L Vujanovic
Journal:  Immunol Res       Date:  2011-08       Impact factor: 2.829

Review 5.  Dendritic cells and natural killer cells in the pathogenesis of HIV infection.

Authors:  Claudio Fortis; Guido Poli
Journal:  Immunol Res       Date:  2005       Impact factor: 2.829

6.  Essential role of the TNF-TNFR2 cognate interaction in mouse dendritic cell-natural killer cell crosstalk.

Authors:  Jun Xu; Ayan K Chakrabarti; Jennifer L Tan; Lisheng Ge; Andrea Gambotto; Nikola L Vujanovic
Journal:  Blood       Date:  2006-12-12       Impact factor: 22.113

7.  Regulation of the human endogenous retrovirus K (HML-2) transcriptome by the HIV-1 Tat protein.

Authors:  Marta J Gonzalez-Hernandez; James D Cavalcoli; Maureen A Sartor; Rafael Contreras-Galindo; Fan Meng; Manhong Dai; Derek Dube; Anjan K Saha; Scott D Gitlin; Gilbert S Omenn; Mark H Kaplan; David M Markovitz
Journal:  J Virol       Date:  2014-05-28       Impact factor: 5.103

8.  Kinome analysis of receptor-induced phosphorylation in human natural killer cells.

Authors:  Sebastian König; Manfred Nimtz; Maxi Scheiter; Hans-Gustaf Ljunggren; Yenan T Bryceson; Lothar Jänsch
Journal:  PLoS One       Date:  2012-01-04       Impact factor: 3.240

9.  Protein Kinase Inhibitors CK59 and CID755673 Alter Primary Human NK Cell Effector Functions.

Authors:  Maxi Scheiter; Björn Bulitta; Marco van Ham; Frank Klawonn; Sebastian König; Lothar Jänsch
Journal:  Front Immunol       Date:  2013-03-18       Impact factor: 7.561

10.  Dendritic cell exosomes directly kill tumor cells and activate natural killer cells via TNF superfamily ligands.

Authors:  Stephan Munich; Andrea Sobo-Vujanovic; William J Buchser; Donna Beer-Stolz; Nikola L Vujanovic
Journal:  Oncoimmunology       Date:  2012-10-01       Impact factor: 8.110

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.